ANTIMICROBIAL RESISTANCE SOLUTIONS
WITH DR. JOHN H. REX
Latest Newsletters
Latest Government Action





















R&D Insight
Can you help?
Antimicrobial resistance poses a catastrophic threat. If we don’t act now, any one of us could go into hospital in 20 years for minor surgery and die because of an ordinary infection that can’t be treated by antibiotics. And routine operations like hip replacements or organ transplants could be deadly because of the risk of infection.
Dame Sally Davies Tweet
FDA: Early endpoints and late endpoints suggest a path to global regulatory convergence (Bart et al.)
Impact of PASTEUR: 9.9m lives saved, ROI of 125:1
FDA AMDAC – Developing Single-Pathogen agents for P. aeruginosa and A. baumannii
Lessons in Discovery from Lynn Silver + Pro-con on alternatives to antibiotics
Categories of resistance: MDR, XDR, PDR, UDR, and (new!) DTR
Developing systemic & inhaled antibiotics for lung infections
Anti-Gram-negative beta-lactams in jeopardy: The rise of PBP3 mutations
What does an antibiotic cost to develop? What is it worth? How to afford it?
Two new oral drugs for gonorrhea!
Scary, Scarier, Scariest (Part 2): What can YOU do about it?
Non-traditional antibiotics: A pipeline review and an analysis of key development challenges
FDA workshop: Insights on inhaled antifungals and antibacterials
The thoughtless person playing with penicillin treatment is morally responsible for the death of the man who succumbs to infection with the penicillin-resistant organism.
Alexander Fleming Tweet
The bipartisan PASTEUR Act is the strongest bill ever written to strengthen antibiotic development and use. It will fix our market failures, expand the pipeline for next generation antibiotics, and save lives. We can’t sit on our hands as this public health crisis arrives – we have to act now.
U.S. Senator Michael Bennet Tweet